Myeloperoxidase-mediated solution demonstrates rapid virucidal properties against the delta variant of SARS-CoV-2

dc.contributor.authorDenys, G. A.
dc.contributor.authorBurningham, K.
dc.contributor.authorDyba, J.
dc.contributor.authorAllen, R. C.
dc.contributor.authorStephens , J. T., Jr.
dc.contributor.departmentMicrobiology and Immunology, School of Medicine
dc.date.accessioned2024-06-20T16:18:47Z
dc.date.available2024-06-20T16:18:47Z
dc.date.issued2022-05
dc.eprint.versionFinal published version
dc.identifier.citationDenys, G. A., Burningham, K., Dyba, J., Allen, R. C., & Stephens, J. T. (2022). Myeloperoxidase-mediated solution demonstrates rapid virucidal properties against the delta variant of SARS-CoV-2. The Journal of Hospital Infection, 123, 189–190. https://doi.org/10.1016/j.jhin.2022.02.013
dc.identifier.urihttps://hdl.handle.net/1805/41655
dc.language.isoen_US
dc.publisherElsevier
dc.relation.isversionof10.1016/j.jhin.2022.02.013
dc.relation.journalJournal of Hospital Infection
dc.rightsPublisher Policy
dc.sourcePMC
dc.subjectSARS-CoV-2
dc.subjectCOVID-19 pandemic
dc.subjectmitigation
dc.subjectmyeloperoxidase-mediated solution (MPMS)
dc.titleMyeloperoxidase-mediated solution demonstrates rapid virucidal properties against the delta variant of SARS-CoV-2
dc.typeArticle
ul.alternative.fulltexthttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864890/
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Denys2022Myeloperoxidase-PubP.pdf
Size:
229.21 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: